Botanical species · safety record

Chrysanthemum indicum

The EFSA Compendium of Botanicals holds 5 constituent measurements and 2 adverse-effect records for Chrysanthemum indicum. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Chrysanthemum indicum L.

5Constituent measurements

2Safety records

4Cited sources

110Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 110 licensed products naming Chrysanthemum indicum as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

Dry
Extract Type TBA

Source material stated

Capitulum
Chrysanthemum indicum - Flower
Dried capitulum
Flower
Flower extract
Flowers
New material
Whole plant

What the records describe

Constituents measured

Plant parts

Preparations

Effect types

Target tissues

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
1,8-cineole	Flower	Essential oil	≤ 7.34 Percent	GC-MS	Resolve DOI
1,8-cineole	Flower	Essential oil	≥ 0.62 Percent	GC-MS	Resolve DOI
Camphor	Flower	Solvent extraction	≥ 0.046 Milligram/gram	GC-MS	Resolve DOI
Camphor	Flower	Solvent extraction	≤ 0.426 Milligram/gram	GC-MS	Resolve DOI
Camphor	Flower	Essential oil	≤ 27.56 Percent	GC-MS	Resolve DOI

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

Effect	Target tissue	Plant part	Preparation	Test organism	Test type	Source
Digestive	Digestive: pancreas	Unspecified	Drying (dehydration)	—	In vitro	Resolve DOI
Developmental	Bone (deprecated)	Flower	Solvent extraction	House mouse (as animal)	Reproduction toxicity	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Zhang, Cong., Qin, Min-Jian., Shu, Pan., Hong, Jun-Li., Lue, Lin., He, Dan-Xia. Chemical Variations of the Essential Oils in Flower Heads of Chrysanthemum indicum L. from China. CHEMISTRY & BIODIVERSITY, 2010, vol. 7, no. 12, p. 2951-2962. DOI
Deng, Chunhui., Mao, Yu., Yao, Ning., Zhang, Xiangmin. Development of microwave-assisted extraction followed by headspace solid-phase microextraction and gas chromatography-mass spectrometry for quantification of camphor and borneol in Flos Chrysanthemi Indici. ANALYTICA CHIMICA ACTA, 2006, vol. 575, no. 1, p. 120-125. DOI
Singh, K. N., Singh, Gajendra. TERATOGENIC EFFECT OF ACE INHIBITOR (LISINOPRIL) AND CHRYSANTHEMUM INDICUM(GULDAUDI) ON HEAD AND FACE REGION OF MICE FETUSES. JOURNAL OF THE ANATOMICAL SOCIETY OF INDIA, 2011, vol. 60, no. 2, p. 181-183.
Adisakwattana, Sirichai., Ruengsamran, Thanyachanok., Kampa, Patcharaporn., Sompong, Weerachat. In vitro inhibitory effects of plant-based foods and their combinations on intestinal alpha-glucosidase and pancreatic alpha-amylase. . Bmc complementary and alternative medicine, 2012, vol. 12, p. 110. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature